Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry

被引:18
作者
Nayak, B. [1 ]
Guleria, S. [1 ]
Varma, M. [1 ]
Tandon, N. [1 ]
Aggarwal, S. [1 ]
Bhowmick, D. [1 ]
Agarwal, S. K. [1 ]
Mahajan, S. [1 ]
Gupta, S. [1 ]
Tiwari, S. C. [1 ]
机构
[1] All India Inst Med Sci, Dept Surg Endocrinol & Nephrol, New Delhi 110029, India
关键词
D O I
10.1016/j.transproceed.2007.01.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Introduction. Steroid-induced osteoporosis is a major problem after organ transplantation. There is considerable evidence that bisphosphonates are effective in decreasing osteoporosis. Aim. This prospective study was carried out to seethe effects of bisphosphonates on bone mineral density (BMD) after successful renal transplantation. Material and methods. Fifty consecutive patients of successful renal transplantation were randomized into two groups. Group A (n = 27) received 35 mg/wk of Alendronate for 6 months after transplantation. Group B (n = 23) did not receive Alendronate and served as a control. Both groups underwent a pretransplant baseline dual-energy X-ray absorptiometry (DEXA) scan of their hips and lumber spines. Both groups received oral calcium and vitamin D supplement. Both groups were matched for the regimen and dose of immunosuppressive drugs. BMD was measured at 3 months and 6 months after transplantation. Results. Both groups showed a decline in BMD in early months posttransplantation. However, the 6-month DEXA scans showed a significant rise in BMD in group A as compared to group B. Conclusion. Bisphosphonates appear to have a beneficial effect on steroid-induced bone loss.
引用
收藏
页码:750 / 752
页数:3
相关论文
共 7 条
[1]
GROTZ WH, 1995, NEPHROL DIAL TRANSPL, V10, P2096
[2]
Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease [J].
Heaf, J ;
Tvedegaard, E ;
Kanstrup, IL ;
Fogh-Andersen, N .
CLINICAL TRANSPLANTATION, 2000, 14 (05) :457-463
[3]
KOO M, 2002, TRANSPL P, V34, P2111
[4]
LINDSAY R, 2001, HARRISONS PRINCIPLES, P2226
[5]
Effects of bisphosphonates on bone loss in the first year after renal transplantation - a meta-analysis of randomized controlled trials [J].
Mitterbauer, Christa ;
Schwarz, Christoph ;
Haas, Martin ;
Oberbauer, Rainer .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) :2275-2281
[6]
Cross-sectional analysis of renal transplantation osteoporosis [J].
Parker, CR ;
Freemont, AJ ;
Blackwell, PJ ;
Grainge, MJ ;
Hosking, DJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) :1943-1951
[7]
Alendronate in kidney transplant patients:: A single-center experience [J].
Toro, J ;
Gentil, MA ;
García, R ;
Pérez-Valdivia, MA ;
Avellano, EG ;
Algarra, GR ;
Pereira, P ;
González-Roncero, F ;
Mateos, J .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (03) :1471-1472